Skip to content

Category: Science Medical

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

By API User

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time … Continued

Men and women may need different medications to avoid broken bones

By API User

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a second hip fracture, subsequent fractures, and death in people prescribed two different classes of bone strengthening medications. The researchers conducted a series of parallel population-based cohort studies in Australia, Hong Kong, … Continued

Coffee scraps help blueberries stay fresher, longer

By API User

Key Facts: UNSW researchers are turning what was once waste into a protective film that could help extend the expiry date of some of Australia’s favourite summer fruits. Ever splurged on a punnet (or few) of blueberries only to find them a wrinkled, grey-flecked disappointment in your fridge a few days later? You’re not alone. … Continued

Global Clinical Experts Gather in Sydney to Advance Adult Duchenne Muscular Dystrophy Care

By API User

Key Facts: Life expectancy for Australians living with DMD have increased from 18 for those borne before 1970, to around 30 today. As adult care remains fragmented and inconsistent between hospitals and States, the Symposium will develop global multi-disciplinary care recommendations.  MEDIA RELEASE A world-first International Symposium dedicated to improving multi-disciplinary clinical care for adults living … Continued

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

By API User

VIENNA–BUSINESS WIRE– AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new … Continued

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

By API User

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety Signals These Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary Endpoints Patients Crossing Over from Placebo to … Continued

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

By API User

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a … Continued